Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Equity ETF median (66 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 19 Aug 2022 – 20 Aug 2026, limited by Aditya Birla Sun Life Nifty 200 Quality 30 ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Aditya Birla Sun Life Nifty 200 Quality 30 ETF | Nifty 500 |
|---|---|---|
| 19 Aug 2022 | ₹100.00 | ₹100.00 |
| 19 Dec 2022 | ₹98.49 | ₹103.40 |
| 20 Apr 2023 | ₹96.20 | ₹97.54 |
| 20 Aug 2023 | ₹108.01 | ₹109.98 |
| 19 Dec 2023 | ₹123.52 | ₹125.81 |
| 19 Apr 2024 | ₹125.98 | ₹133.79 |
| 19 Aug 2024 | ₹153.76 | ₹151.87 |
| 19 Dec 2024 | ₹146.82 | ₹149.33 |
| 20 Apr 2025 | ₹134.54 | ₹142.30 |
| 20 Aug 2025 | ₹145.43 | ₹151.89 |
| 19 Dec 2025 | ₹149.79 | ₹155.40 |
| 20 Apr 2026 | ₹143.47 | ₹150.07 |
| 20 Aug 2026 | ₹146.72 | ₹154.32 |
| Metric | Aditya Birla Sun Life NAV ₹21.68 Very High risk ★★★☆☆ | Category median Equity ETF · 66 funds |
|---|---|---|
| +0.88% | +3.95% | |
| +10.73% | +11.55% | |
| — | +10.41% | |
| — | +11.81% | |
| +10.05% | +8.19% | |
| +7.95% | — | |
| +13.15% | +13.71% | |
| — | +14.22% | |
| — | +12.98% | |
| Risk | ||
| 13.38% | 17.16% | |
| 0.32 | 0.22 | |
| 0.44 | 0.32 | |
| -22.46% | -20.98% | |
| Nifty 500 | — | |
| -0.69% | +0.65% | |
| 0.97 | 1.00 | |
| 91.6% | 101.0% | |
| 92.5% | 97.0% | |
| 0.35% | 0.37% | |
| ₹26.06Cr | ₹91.02Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| 19 Aug 2022 | — | |
| 30 | — | |
| 46.5% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.